Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133552 | 1.00 | BACE1 (0.30) | BACE1 | |
| SCHEMBL1535723 | 0.99 | BACE1 (0.31) | BACE1 | |
| SCHEMBL4604431 | 0.88 | — | — | |
| SCHEMBL1942951 | 0.87 | BACE1 (0.32) | BACE1 | |
| SCHEMBL4605446 | 0.87 | — | — | |
| SCHEMBL2384831 | 0.85 | TSHR (0.34) | — | |
| SCHEMBL29649091 | 0.85 | — | — | |
| SCHEMBL1535715 | 0.84 | — | — | |
| SCHEMBL1535718 | 0.83 | — | — | |
| SCHEMBL4650164 | 0.83 | BACE1 (0.31) | BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160137779-A1 | CURABLE EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF | DAICEL CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
| US-20150133629-A1 | DIEPOXY COMPOUND AND METHOD FOR PRODUCING SAME | DAICEL CORPORATION (JP) | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150133629-A1 | DIEPOXY COMPOUND AND METHOD FOR PRODUCING SAME | DHPS, DPY30, ALOX5 | BACE1 4388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.